Shopping Cart
- Remove All
 
Your shopping cart is currently empty
P2Y14R antagonist 2 (compound 39) is an effective and selective orally-active antagonist of P2Y14R with an IC50 of 0.40 nM. It exhibits anti-inflammatory properties and holds potential for use in studying colitis.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 
| Description | P2Y14R antagonist 2 (compound 39) is an effective and selective orally-active antagonist of P2Y14R with an IC50 of 0.40 nM. It exhibits anti-inflammatory properties and holds potential for use in studying colitis.  | 
| Targets&IC50 |  P2Y14 Receptor:0.40 nM  | 
| In vivo | The compound P2Y14R antagonist 2, administered rectally at doses of 50 and 100 µM in a volume of 100µL to male C57BL/6 mice (colitis) for 7 days, exhibited anti-inflammatory effects in mice with colitis. This compound reduced symptoms such as DSS-induced body weight loss, loose stools, rectal bleeding, and colon shortening while also decreasing the spleen weight index.  | 
| Molecular Weight | 372.37 | 
| Formula | C18H13FN2O4S | 
| Cas No. | 2989271-65-8 | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.